Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Northwest Biotherapeutics Inc (NASDAQOTCBB:NWBO)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQOTCBB:NWBO will perform against the market?

Add Stock to CAPS Watchlist

All Players

33 Outperform
41 Underperform
 

All-Star Players

0 Outperform
29 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTCBB:NWBO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Palmcroft (< 20)
Submitted June 11, 2021

DCVax personalized cancer vaccine platform. GBM tumors first up, standard of care will include DCVax by mid-2022.Phase 3 data release through publication probably by August.

TMFang4apples (22.21)
Submitted October 16, 2020

The stinkiest bioturd of all.

NASDAQOTCBB:NWBO Summary

Fools bullish on NASDAQOTCBB:NWBO are also bullish on:

Fools bearish on NASDAQOTCBB:NWBO are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NWBO.

Recs

2
Member Avatar Palmcroft (< 20) Submitted: 6/11/2021 2:45:51 PM : Outperform Start Price: $1.59 NASDAQ OTC:NWBO Score: -58.85

DCVax personalized cancer vaccine platform.

GBM tumors first up, standard of care will include DCVax by mid-2022.

Phase 3 data release through publication probably by August.

Recs

1
Member Avatar TMFang4apples (22.21) Submitted: 10/16/2020 1:05:41 PM : Underperform Start Price: $1.67 NASDAQ OTC:NWBO Score: +84.19

The stinkiest bioturd of all.

Recs

2
Member Avatar zzlangerhans (98.81) Submitted: 10/21/2016 11:16:46 PM : Underperform Start Price: $0.56 NASDAQ OTC:NWBO Score: +74.82

Every once in a while I check in to see what Northwest is up to. Recently there was a price spike but I didn't have time to look into it. It turns out there was nothing to justify it. Northwest Bio doesn't have the guts to issue an earnings PR, likely because they would have to admit they are making no clinical progress but continuing to feed cash from dilutive financings into Linda Powers' slush fund Cognate. They filed a 10Q as required but it contains nothing material regarding their progress or lack thereof in clinical trials. The one positive is that it does appear that the stock is in a death spiral with successive financings at lower and lower share price that are unable to keep up with the quarterly burn. The next 10Q should be interesting. Of course, given Northwest's history, there's no limit to the reverse splitting, nonsense PR spouting we might expect once Powers is backed into a corner.

Leaderboard

Find the members with the highest scoring picks in NWBO.

Score Leader

walt373

walt373 (99.98) Score: +392.95

The Score Leader is the player with the highest score across all their picks in NWBO.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
walt373 99.98 8/19/2011 Underperform 5Y $8.00 -90.37% +302.58% +392.95 0 Comment
walt393 99.96 8/18/2011 Underperform 5Y $7.68 -89.97% +290.35% +380.32 0 Comment
Europecv 26.49 10/18/2011 Underperform 5Y $9.28 -91.70% +278.53% +370.22 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. cjlee001 85.28 10/27/2011 Underperform 5Y $8.89 -91.33% +256.31% +347.64 0 Comment
HedgeFund007 24.79 10/28/2011 Underperform 1Y $8.32 -90.74% +255.28% +346.02 0 Comment
wagnerf60 81.45 6/2/2011 Underperform 5Y $14.00 -94.50% +246.67% +341.16 0 Comment
HikerAnthony 97.15 5/26/2011 Underperform 5Y $11.36 -93.22% +244.44% +337.65 0 Comment
vettelvettel 99.83 5/23/2011 Underperform 5Y $10.72 -92.81% +244.72% +337.54 0 Comment
williamstep 97.89 5/23/2011 Underperform 5Y $10.58 -92.71% +244.78% +337.49 0 Comment
thefooloffoools 97.29 5/23/2011 Underperform 5Y $9.15 -91.58% +244.57% +336.15 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NWBO.